Cancer of unknown primary: a population-based analysis of temporal change and socioeconomic disparities

od Urban, D, Rao, A, Bressel, M, Lawrence, Y R, Mileshkin, L
Wydane 2013

An analysis of the utilisation of chemoprophylaxis against Pneumocystis jirovecii pneumonia in patients with malignancy receiving corticosteroid therapy at a cancer hospital

od Worth, L J, Dooley, M J, Seymour, J F, Mileshkin, L, Slavin, M A, Thursky, K A
Wydane 2005

A phase I trial of high-dose palliative radiotherapy plus concurrent weekly Vinorelbine and Cisplatin in patients with locally advanced and metastatic NSCLC

od Michael, M, Wirth, A, Ball, D L, MacManus, M, Rischin, D, Mileshkin, L, Solomon, B, McKendrick, J, Milner, A D
Wydane 2005

Rapid screening for depression – validation of the Brief Case-Find for Depression (BCD) in medical oncology and palliative care patients

od Jefford, M, Mileshkin, L, Richards, K, Thomson, J, Matthews, J P, Zalcberg, J, Jennens, R, McLachlan, S-A, Wein, S, Antill, Y, Clarke, D M
Wydane 2004

Study of autologous dendritic cell therapy targeting Mucin 1 as a treatment for the maintenance of ovarian cancer patients in remission

od Goh, J, Mason, J, Chan, J, Moradi, M, Berek, J, Beningno, B, Mileshkin, L, Recio, F, Tchabo, N, Rossi, E, Eisenberg, P, Rose, P, Mitchell, P, Young, J, Matos, M, Secord, A, Davy, M, Gargosky, S, Gray, H
Wydane 2013

Progression-free and overall survival in ovarian cancer patients treated with CVac, a mucin 1 dendritic cell therapy in a randomized phase 2 trial

od Gray, H. J., Benigno, B., Berek, J., Chang, J., Mason, J., Mileshkin, L., Mitchell, P., Moradi, M., Recio, F. O., Michener, C. M., Secord, A. Alvarez, Tchabo, N E., Chan, J. K., Young, J., Kohrt, H., Gargosky, S. E., Goh, J. C.
Wydane w J Immunother Cancer (2016)

Prediction model for regional or distant recurrence in endometrial cancer based on classical pathological and immunological parameters

od Versluis, M A, de Jong, R A, Plat, A, Bosse, T, Smit, V T, Mackay, H, Powell, M, Leary, A, Mileshkin, L, Kitchener, H C, Crosbie, E J, Edmondson, R J, Creutzberg, C L, Hollema, H, Daemen, T, de Bock, G H, Nijman, H W
Wydane w Br J Cancer (2015)

Clinical consequences of upfront pathology review in the randomised PORTEC-3 trial for high-risk endometrial cancer

od de Boer, S M, Wortman, B G, Bosse, T, Powell, M E, Singh, N, Hollema, H, Wilson, G, Chowdhury, M N, Mileshkin, L, Pyman, J, Katsaros, D, Carinelli, S, Fyles, A, McLachlin, C M, Haie-Meder, C, Duvillard, P, Nout, R A, Verhoeven-Adema, K W, Putter, H, Creutzberg, C L, Smit, V T H B M
Wydane w Ann Oncol (2018)